Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication Sort descending | Description |
---|---|---|---|---|---|---|---|---|
DOXAZOSIN MESYLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 29-Oct-2021 | 1-Nov-2021 | NA | NA | In USP Doxazosin Related Compound D RS: Change 1,4-Benzodioxane-2-carboxylic acid. C9H8O5 196.16 to: 1,4-Benzodioxane-2-carboxylic acid. C9H8O4 180.16 |
MUPIROCIN NASAL OINTMENT | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
N-Benzoyl-L-arginine Ethyl Ester Hydrochloride | REAGENT SPECIFICATIONS | USPNF Online | Online | 30-Sep-2022 | 1-Dec-2022 | NA | NA | Change Crystallized Trypsin (USP Monograph). to: Trypsin (USP Monograph). |
ARGATROBAN | CHEMICAL INFORMATION | USP41–NF36 | 346 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | See https://www.uspnf.com/sites/default/files/usp_pdf/EN/february_2019_errata_image1.pdf for correction |
GLYCYL-L-TYROSINE | IMPURITIES/Related Compounds | USPNF Online | Online | 24-Feb-2023 | 1-Jun-2023 | NA | NA | In Buffer solution: Change Dissolve 6.84 g of potassium phosphate in 1000 mL of water. to: Dissolve 6.84 g of monobasic potassium phosphate in 1000 mL of water. |
GUANABENZ ACETATE | IMPURITIES/Limit of 2,6-Dichlorobenzaldehyde/Chromatographic system | USP42–NF37 | 2129 | 31-May-2019 | 1-Jun-2019 | NA | NA | In Column: Change 1.8-mm × 3-mm; to: 1.8-m × 3-mm; |
UREA C 13 | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Isotopic Purity/Chromatographic system: Change Flow rate: Flow rate to: Flow rate: 1 mL/min |
DESFLURANE | CHEMICAL INFORMATION | USP42–NF37 | 1230 | 27-Sep-2019 | 1-Oct-2019 | NA | NA | Change (±)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether to: (±)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether; 2-(Difluoromethoxy)-1,1,1,2-tetrafluoroethane. |
METHYLNALTREXONE BROMIDE | CHEMICAL INFORMATION | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | Correct the chemical structure |
RALTEGRAVIR TABLETS | DEFINITION | USP43–NF38 | 3834 | 24-Apr-2020 | 1-May-2020 | NA | NA | Change (C20H20FN6O5) to: (C20H21FN6O5) |
FUROSEMIDE TABLETS | Limit of furosemide related compound B | USP43–NF38 | 2056 | 31-Jul-2020 | 1-Aug-2020 | NA | NA | Change Mobile phase, Diluting solution, System suitability solution, and Chromatographic system—Prepare as directed in the test for Related compounds under Furosemide. to: Mobile phase—Prepare a… Read More |
AMLODIPINE AND OLMESARTAN MEDOXOMIL TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 26-Feb-2021 | 1-Mar-2021 | NA | NA | In USP Amlodipine Related Compound A RS: Change 522.93 to: 522.94 |
ZIPRASIDONE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 4699 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Ziprasidone Related Compound F RS: Change 2-(2-Amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetic acid. C21H23ClN4O2S 430.95 to: Sodium 2-(2-… Read More |
ONDANSETRON ORALLY DISINTEGRATING TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Ondansetron Related Compound A RS: Change 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. C16H20N2O · HCl 292.80 to: 3-[(Dimethylamino)methyl]-9-methyl-1,2,… Read More |
AMMONIUM GLYCYRRHIZATE | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change 840.08 to: 839.97 |
LEVALBUTEROL INHALATION SOLUTION | IMPURITIES/Limit of S-Albuterol | USP42–NF37 | Online | 26-Apr-2019 | 1-May-2019 | NA | NA | In Mobile phase: Change ▲Acetonitrile, methanol, and acetic acid (50:50). To each liter of the solution add 3 mL of acetic acid and 1 mL of triethylamine.▲ (USP 1-May-2019) to: Acetonitrile and methanol (50:50… Read More |
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change Uniformity of Dosage Units 〈905〉 Procedure for content uniformity to: Uniformity of Dosage Units 〈905〉: Meets the requirements Procedure for content uniformity, chewable tablets only AND In … Read More |
BUSPIRONE HYDROCHLORIDE | IDENTIFICATION/B. | USP42–NF37 | 618 | 26-Jul-2019 | 1-Aug-2019 | NA | NA | Change relative retention time to: retention time |
TELMISARTAN TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Dissolution 〈711〉/Test 1/Analysis: Change Determine the percentage of telmisartan (C33H30N4O2) dissolved: Result = (AU × CS × V × 100)/(A… Read More |
POLYETHYLENE GLYCOL | CHEMICAL INFORMATION | USP42–NF37 | 5882 | 31-Jan-2020 | 1-Feb-2020 | NA | NA | See https://www.uspnf.com/sites/default/files/usp_pdf/EN/january-2020-errata-with-image.pdf for correction |
METOPROLOL SUCCINATE | USP Reference standards <11> | USP43–NF38 | 2917 | 29-May-2020 | 1-Jun-2020 | NA | NA | In USP Metoprolol Related Compound C RS: Change (±)4-[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde. C13H19NO3 237.29 to: 4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride. C13… Read More |
OIL-SOLUBLE VITAMINS WITH MINERALS TABLETS | ADDITIONAL REQUIREMENTS/Labeling | USP43–NF38 | 5378 | 30-Oct-2020 | 1-Nov-2020 | NA | NA | In footnote 1: Change 1 mg of -alpha tocopheryl acetate to: 1 mg of all-rac-alpha tocopheryl acetate |
ATORVASTATIN CALCIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 414 | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In USP Atorvastatin Related Compound C RS: Change Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt. to: Calcium (3R,5R… Read More |
BIFIDOBACTERIUM LONGUM SUBSP. LONGUM | DEFINITION | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | Change Bifidobacteriumlongum subsp. longum comprises to: Bifidobacterium longum subsp. longum comprises |
ISOSORBIDE DINITRATE EXTENDED-RELEASE TABLETS | Dissolution <711> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | In Test 2: Change Determine the amount of isosorbide dinitrate (C6H9NO6) dissolved by employing the following method. to: Determine the amount of isosorbide dinitrate (C6H8N2O… Read More |
APREPITANT CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change Test 1 Dilute 1 mL of phosphoric acid with water to 1 L. to: Test 1 AND Change Dilute phosphoric acid: to: Dilute phosphoric acid: Dilute 1 mL of phosphoric acid with water to 1 L. |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
FLUDROCORTISONE ACETATE TABLETS | IMPURITIES/Organic Impurities/Table 1 | Second Supplement to USP41–NF36 | 8843 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In footnote a: Change 9-Fluoro-11β,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate. to: 9-Fluoro-11β,17,21-trihydroxypregn-4-ene-3,20-dione. |
CALCIUM LACTATE | CHEMICAL INFORMATION | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Calcium lactate (1:2) hydrate to: Calcium lactate hydrate AND Change Calcium lactate (1:2) pentahydrate to: Calcium lactate pentahydrate |
LIQUID GLUCOSE | ASSAY/Reducing Sugars | USP42–NF37 | 5741 | 31-May-2019 | 1-Jun-2019 | NA | NA | In the variable definition list in Analysis: Change CU = concentration of dextrose equivalent to: CU = concentration of Liquid Glucose |
FOSAMPRENAVIR CALCIUM TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Dissolution 〈711〉/Medium: Change 26.7 g/L of sodium acetate trihydrate in water. Add 133 mL of glacial acetic acid to this solution, and then dilute with water to 10 L; 900 mL. to: 0.02 M sodium acetate buffer, pH 3.5, prepared as follows.… Read More |
<55> BIOLOGICAL INDICATORS—RESISTANCE PERFORMANCE TESTS | D-VALUE DETERMINATION | USP42–NF37 | 6385 | 25-Oct-2019 | 1-Nov-2019 | NA | NA | In the third paragraph in Procedure: Change stated spore filter to: stated spore titer |
OIL-SOLUBLE VITAMINS TABLETS | STRENGTH | USP43–NF38 | 5356 | 24-Apr-2020 | 1-May-2020 | NA | NA | In Vitamin E, Method 3/Analysis: Change alpha -ocopheryl acetate to: alpha-tocopheryl acetate |
CARTEOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION | Assay | USP43–NF38 | 789 | 28-Aug-2020 | 1-Sep-2020 | NA | NA | Change pH 6.0 buffer, Mobile phase, Diluent, Standard preparation, Resolution solution, and Chromatographic system—Proceed as directed in the Assay under Carteolol Hydrochloride. to: … Read More |
GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 2128 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Glyburide Related Compound A RS: Change 368.84 to: 368.83 |
〈643〉 TOTAL ORGANIC CARBON | PROCEDURES | USPNF 2021 ISSUE 1 | Online | 27-Aug-2021 | 1-Sep-2021 | NA | NA | In 1. Bulk Water/1.10 System suitability: Change rE = 100 × [(rC/rL) to: rE = 100 × (rC/rL) |
PROPYLENE GLYCOL DIACETATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In Analysis: Change rS = sum of all the peak areas, excluding the solvent peaks from the Standard solution to: rS = sum of all the peak areas, excluding the solvent peaks from the Sample solution… Read More |
<871> SUTURES--NEEDLE ATTACHMENT | PROCEDURE | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Removable Needle Attachment: Change For USP sizes 5-0 through 2-0, to: For USP sizes 5-0 through 2, |
MESO-ZEAXANTHIN | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
REAGENTS AND REFERENCE TABLES | REAGENT SPECIFICATIONS | USP42–NF37 | 6104 | 26-Apr-2019 | 1-May-2019 | NA | NA | In Ferric Nitrate: Change [10421-48-4]. to: [7782-61-8]. |
ATORVASTATIN CALCIUM TABLETS | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: Mr1 = molecular weight of atorvastatin, 558.65 M… Read More |
OXALIPLATIN INJECTION | IMPURITIES/Limit of Oxalic Acid/Chromatographic system | First Supplement to USP42–NF37 | 8781 | 26-Jul-2019 | 1-Aug-2019 | NA | NA | In Column: Change L31 to: L81 |
OLMESARTAN MEDOXOMIL TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test 5/Apparatus 2: Change 50 rpm. Use peak vessels. to: 50 rpm. Use apex vessels. |
CETIRIZINE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 915 | 24-Apr-2020 | 1-May-2020 | NA | NA | In USP Cetirizine Related Compound A RS: Change 506.98 to: 506.97 |
TETRACAINE HYDROCHLORIDE | IMPURITIES/Organic Impurities | USP43–NF38 | 4295 | 29-May-2020 | 1-Jun-2020 | NA | NA | In Table 2: Change Tetracaine hydrochloride related compound B 1.7 0.4 Tetracaine hydrochloride related compound C 2.1 0.4 to: Tetracaine related compound B 1.7 0.4 Tetracaine related compound C 2.1 0.4 |
GELATIN | SPECIFIC TESTS/Sulfur Dioxide | Harmonization (Official May 01, 2020) | 5783 | 30-Oct-2020 | 1-Nov-2020 | NA | NA | In three instances in Analysis: Change 0.1 M sodium hydroxide to: Titrant AND In the equation: Change M to: N AND In the variable definition list: Change M = actual molarity of the … Read More |
MECLOFENAMATE SODIUM | CHEMICAL INFORMATION | USP42–NF37 | 2706 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | Change 336.15 to: 336.14 AND Change [6385-02-0]; to: [67254-91-5]; AND Change UNII: 9MMQ0YER4E. to: UNII: 94NJ818U2W. |
SECOBARBITAL SODIUM | OTHER REQUIREMENTS | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | Change Where the label states that Seco barbital Sodium is sterile, it meets the requirements for Sterility Tests 〈71〉 and for Bacterial endotoxins under Secobarbital Sodium for Injection. Where the label states that Secobarbital Sodium… Read More |
LEUCOVORIN CALCIUM FOR INJECTION | ASSAY/Procedure/Chromatographic system | USP43–NF38 | 2569 | 24-Apr-2020 | 1-May-2020 | NA | NA | Delete Run time: 2 times the retention time of the leucovorin peak |
PROPYLENE CARBONATE | ASSAY/Procedure/Titrimetric system | USP43–NF38 | 5986 | 26-Jun-2020 | 1-Jul-2020 | NA | NA | In Mode: Change Direct titration to: Residual titration |